Nat. Rev. Cardiol. doi: /nrcardio

Slides:

Advertisements

Similar presentations

Nat. Rev. Cardiol. doi: /nrcardio

Advertisements

Nat. Rev. Cardiol. doi: /nrcardio

Figure 7 Mendelian randomization of overlapping exposures

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Muscle structure

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Different manifestations of myocardial ischaemia

Figure 4 BMI and mortality in patients with heart failure

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Old age, metabolites, and chronic inflammation

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Mechanisms of metastatic growth in the heart

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Global rates of sodium, fruit, and vegetable intake

Figure 1 Antiplatelet and anticoagulant pathways

Figure 2 Size categorization of airborne pollutants

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Three-year survival rates on the basis of body composition

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Health-care system today

Figure 1 Cardiovascular risk and disease across the life-course

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Decision tree integrating the assessment,

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Neural crest cell migration

Figure 2 Global cost of HF per capita in 2012

Figure 5 Examples of biomarker-guided trials

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Manual thrombus aspiration

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Milestones in coronary angioplasty

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Challenges for big data applications in cardiovascular care

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 Gross and histopathological characteristics of cardiac myxoma

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 5 Mendelian randomization of biomarkers on the same pathway

Nat. Rev. Cardiol. doi: /nrcardio

Figure 5 Bioresorbable vascular scaffold apposition and strut coverage

Figure 6 Cardiac fibroma

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 12 Cardiac gossypiboma

Figure 6 The neurogenic components of angina

Observed (symbols) and model predicted (lines) dopamine time courses in rats following D-amphetamine administration. Observed (symbols) and model predicted.

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 Electrocardiogram patterns associated with Brugada syndrome

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Impaired mitochondrial capacity and function in heart failure

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Presentation transcript:

Nat. Rev. Cardiol. doi:10.1038/nrcardio.2017.131 Figure 1 Possible combinations of different classes of antianginal drugs Figure 1 | Possible combinations of different classes of antianginal drugs. The schematic shows useful combinations (green lines), combinations that are not recommended (red lines), possible combinations (blue solid lines), and drugs with similar actions (blue dashed lines). Ferrari, R. et al. (2017) A ‘diamond’ approach to personalized treatment of angina Nat. Rev. Cardiol. doi:10.1038/nrcardio.2017.131